You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 24, 2024

TRIZIVIR Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Trizivir, and when can generic versions of Trizivir launch?

Trizivir is a drug marketed by Viiv Hlthcare and is included in one NDA.

The generic ingredient in TRIZIVIR is abacavir sulfate; lamivudine; zidovudine. There are twelve drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the abacavir sulfate; lamivudine; zidovudine profile page.

Drug patent expirations by year for TRIZIVIR
Drug Prices for TRIZIVIR

See drug prices for TRIZIVIR

Paragraph IV (Patent) Challenges for TRIZIVIR
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
TRIZIVIR Tablets abacavir sulfate; lamivudine; zidovudine 300 mg/150 mg/ 300 mg 021205 1 2011-03-22

US Patents and Regulatory Information for TRIZIVIR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Viiv Hlthcare TRIZIVIR abacavir sulfate; lamivudine; zidovudine TABLET;ORAL 021205-001 Nov 14, 2000 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for TRIZIVIR

International Patents for TRIZIVIR

See the table below for patents covering TRIZIVIR around the world.

Country Patent Number Title Estimated Expiration
Japan 2000143662 ANTIVIRAL SUBSTITUTED 1,3-OXATHIOLANE ⤷  Sign Up
Austria A88987 ⤷  Sign Up
Austria 183508 ⤷  Sign Up
Czechoslovakia 9104109 ⤷  Sign Up
Poland 187085 ⤷  Sign Up
African Intellectual Property Organization (OAPI) 10616 Synergistic combinations of zidovudine 1592u89 and3tc or ftc ⤷  Sign Up
Germany 69622386 ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for TRIZIVIR

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0817637 CA 2005 00028 Denmark ⤷  Sign Up
0434450 SPC/GB99/032 United Kingdom ⤷  Sign Up PRODUCT NAME: ABACAVIR, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT OR DERIVATIVE INCLUDING ABACAVIR SULPHATE; REGISTERED: CH CH 55048 001 19990628; CH CH 55049 002 19990628; UK EU/1/99/112/001 19990708; UK EU/1/99/112/002 19990708
0817637 C300195 Netherlands ⤷  Sign Up PRODUCT NAME: ABACAVIR, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDB AAR ZUURADDITIEZOUT, IN HET BIJZONDER HET HEMISULFAAT, EN LAMIV UDINE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZUURADDITIEZOUT; REGISTRTION NO/DATE: EU/04/298/001-002 20041217
0382526 C960025 Netherlands ⤷  Sign Up PRODUCT NAME: LAMIVUDINUM, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AAN- VAARDBAAR ZOUT; REGISTRATION NO/DATE: EU/1/96/015/001 - EU/1/96/015/002 19960808
0817637 C00817637/01 Switzerland ⤷  Sign Up PRODUCT NAME: ABACAVIR + LAMIVUDIN; REGISTRATION NUMBER/DATE: SWISSMEDIC 56977 31.10.2005
0382526 SPC/GB96/043 United Kingdom ⤷  Sign Up PRODUCT NAME: LAMIVUDINE, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT; REGISTERED: CH 53662 19960228; CH 53663 19960228; UK EU/1/96/015/001 19960808; UK EU/1/96/015/002 19960808
0817637 300195 Netherlands ⤷  Sign Up 300195, 20160328, EXPIRES: 20191216
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.